F.D.A. Approves GHB, a ‘Date Rape’ Drug, for Rare Sleeping Disorder
Well - New York Times,
Jazz Pharmaceuticals brought in more than $1.7 billion last year selling GHB to narcolepsy patients. With the new approval…
494 Placebo-Controlled, Double-Blind, Randomized Withdrawal Study of Lower-Sodium Oxybate in Adults With Idiopathic Hypersomnia
Overview of attention for article published in Sleep, May 2021
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (92nd percentile)
-
High Attention Score compared to outputs of the same age and source (82nd percentile)
Readers on
- mendeley
- 6 Mendeley